V
Rekvina Laboratories
VINRKLB Share Price
Healthcare27.14
as on 27 Feb 2026 at 15:15
BSE
Market Cap
₹16 Cr
PE Ratio
-68.20
ROCE
41.27%
VINRKLB Fundamentals
Company Valuation
Market Cap (₹ Cr.)
16
PE Ratio
-68.20
PB Ratio
-21.31
Dividend Yield
-
ROE
41.27%
ROCE
41.27%
Book Value (₹)
-1.25
Face Value (₹)
5.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 41.30% | 41.30% | 41.30% | 41.30% | 41.30% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 47.58% | 44.08% | 45.96% | 45.99% | 45.99% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
VINRKLB Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Microcap
BSE Scrip Code
526075
NSE Scrip Name
VINRKLB
ISIN
INE092O01028



